Nomura Holdings
NVO

Nomura Holdings’s Novo Nordisk NVO Stock Holding History

Nomura Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
314,926
-147,983
-32% -$6.36M 0.02% 437
2026
Q1 		$17M Buy
462,909
+106,023
+30% +$5.02M 0.05% 290
2025
Q4 		$18.2M Sell
356,886
-617,984
-63% -$31.6M 0.02% 342
2025
Q3 		$54.1M Buy
974,870
+607,044
+165% +$35.5M 0.08% 149
2025
Q2 		$25.4M Buy
367,826
+164,975
+81% +$11.2M 0.05% 209
2025
Q1 		$14.1M Buy
202,851
+50,057
+33% +$4.13M 0.03% 377
2024
Q4 		$13.1M Buy
152,794
+137,856
+923% +$14.9M 0.02% 429
2024
Q3 		$1.78M Buy
14,938
+11,471
+331% +$1.53M ﹤0.01% 976
2024
Q2 		$495K Buy
3,467
+1,331
+62% +$176K ﹤0.01% 1326
2024
Q1 		$274K Sell
2,136
-6,746
-76% -$803K ﹤0.01% 1383
2023
Q4 		$919K Buy
8,882
+3,072
+53% +$304K ﹤0.01% 1201
2023
Q3 		$528K Buy
+5,810
New +$512K ﹤0.01% 1117
2020
Q1 		– Sell
-36,860
Closed -$1.07M – 1140
2019
Q4 		$1.07M Buy
+36,860
New +$1.02M ﹤0.01% 782
2014
Q4 		– Sell
-65,752
Closed -$1.39M – 2580
2014
Q3 		$1.39M Buy
65,752
+3,042
+5% +$70K ﹤0.01% 1285
2014
Q2 		$1.44M Sell
62,710
-1,016
-2% -$22.4K ﹤0.01% 1293
2014
Q1 		$1.45M Buy
63,726
+15,896
+33% +$339K ﹤0.01% 1319
2013
Q4 		$880K Buy
47,830
+28,530
+148% +$497K ﹤0.01% 1039
2013
Q3 		$327K Sell
19,300
-53,250
-73% -$896K ﹤0.01% 1633
2013
Q2 		$1.13M Buy
+72,550
New +$1.21M 0.01% 932

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nomura Holdings's NVO Position: Q2 2026 in Review

Nomura Holdings reduced its Novo Nordisk (NVO) stake by 32% in Q2 2026, selling an estimated $6.36M and leaving 314,926 shares worth $15.1M. The position accounts for 0.02% of the portfolio, ranked #437.

Nomura Holdings first reported a position in NVO in Q2 2013 and has held it in 19 quarters since. The position peaked at $54.1M in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Nomura Holdings held 314,926 shares of Novo Nordisk worth $15.1M as of Q2 2026.
  • Nomura Holdings sold 147,983 Novo Nordisk shares in Q2 2026, an estimated $6.36M.
  • Novo Nordisk made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #437 holding.
  • Nomura Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 19 quarters since.
  • Nomura Holdings's Novo Nordisk position peaked at $54.1M in Q3 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.